Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Accelerated Technology Laboratories, Inc. (ATL) and Institute for Biopharmaceutical Research (IBR, Inc.) Partner to Provide Pipette Calibration Solutions for GLP and GMP Compliant Laboratories

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
Synergies between ATL and IBR products are complementary and offer numerous benefits.

Accelerated Technology Laboratories, Inc. (ATL), a premier supplier of Laboratory Data Management Solutions, has announced a new partnership with Institute for Biopharmaceutical Research (IBR, Inc.) - a leader in turnkey calibration software.  

ATL is the North American Partner for IBR and will be offering Check&Track v2.0 to GLP and GMP compliant laboratories. Check&Track v2.0 offers just-in-time management of certification and recordkeeping for pipettes, specific to ISO 9000, ISO 8655, DIN 12650 and NCCLS requirements. Key benefits of this technology include automatic collection of data from an RS232 balance, automatic calibration procedures (manufacturer specific and custom macros), guided data collection during calibration, online input for environmental parameters, automatic statistics and qualification according to the specifications of the manufacturer, complete pipette history, schedules for pipette's calibration and balance service administration.  

"ATL is excited for the opportunity to team up with IBR for tighter integration of our complementary
products. They share our passion for automation and providing best-of-class tools, allowing customers to be more productive and efficient," said Dr. Christine Paszko, ATL's Vice President of Sales and Marketing.

"IBR is proud having found ATL as a highly professional partner for his software Check &Track and appreciates the fascinating collaboration dedicated to convert emerging needs in the quality managed laboratory to sophisticated products," said Dr. René Moser, IBR's CEO and CSO.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ATL to Exhibit Laboratory Automation and LIMS at VA AWWA/VWEA Good Laboratory Practice Conference 2014
ATL will demonstrate Sample Master v10 - a 100 percent web-based LIMS, built on .NET framework.
Saturday, July 12, 2014
ATL to Host Webcast Introducing Sample Master v10
Webinar to share information on ATL's Sample Master v10
Tuesday, March 11, 2014
ATL to Host Webcast: LIMS Without Limits - Using Mobile Technology
Accelerated Technology Laboratories' webinar to share information leveraging LIMS in a mobile world.
Tuesday, August 13, 2013
Accelerated Technology Laboratories, Inc. and WaterTrax Partnership Announced
Seamless LIMS Integration to Water and Wastewater Clients Now Available
Thursday, January 10, 2013
Accelerated Technology Laboratories, Inc. Establishes Partnership with ANDIA LTDA.
Accelerated Technology Laboratories, Inc. (ATL) announce that ANDIA LTDA.(ANDIA)is now an ATL Certified Sales Agent and will market and sell ATL’s Sample Master® LIMS and laboratory automation solutions in Colombia.
Thursday, December 02, 2010
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!